For years, medical AI has generated plenty of excitement but has struggled to show it can make money. That situation may be starting to change, as one Chinese provider of healthcare technology prepares to mark an earnings milestone.
过去几年，医疗AI始终站在技术光环的中心，却往往被视为难以实现盈利。直到近日，医渡科技有限公司（2158.HK）公布预期实现创立11年多以来首次全年盈利，可能成为整个医疗AI行业的一个关键节点。
Yidu Tech Inc. (2158.HK) announced on April 20 it expects to post the first annual profit in its 11-year history, potentially marking an inflection point for the broader AI-powered healthcare sector.
公司预计，截至2026年3月31日止财年，由上年约1.18亿元净亏损，转为净利润4,100万至5,600万元（约820万美元）。公司将这一转变归因于两个因素，其一是AI能力融入产品后带动新订单显著增加，其二是产品附加值提升与营运效率改善推动毛利率上升。
The supplier of big data and tech solutions for the medical sector projected a net profit of between 41 million yuan and 56 million yuan ($6 million and $8.2 million) for its financial year to the end of March, rebounding from a loss of around 118 million yuan in the previous year.
这一盈利并非毫无迹象可循，回看公司截至2025年9月的中期业绩，其转折其实已经开始显现。期内收入达3.58亿元，同比增长8.7%，结束过去的收缩态势；毛利率由35.6%提升至37.4%；更关键的是，经营亏损大幅收窄71%至1,571万元，净亏损亦缩减72%至1,576万元。